Publications by authors named "Peter Demarsh"

Claim this Profile
R
Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats.
Jennifer L Hoover, Christine M Singley, Philippa Elefante, Peter DeMarsh, Magdalena Zalacain

Antimicrob Agents Chemother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Jennifer Hoover, Thomas Lewandowski, Robert J Straub, Steven J Novick, Peter DeMarsh

Antimicrob Agents Chemother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity.
Thomas Lewandowski, Jianzhong Huang, Frank Fan, Shannon Rogers, Daniel Gentry, Peter Demarsh

Antimicrob Agents Chemother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis